HK1257228A1 - 用螯合物成像的方法 - Google Patents

用螯合物成像的方法

Info

Publication number
HK1257228A1
HK1257228A1 HK18116264.5A HK18116264A HK1257228A1 HK 1257228 A1 HK1257228 A1 HK 1257228A1 HK 18116264 A HK18116264 A HK 18116264A HK 1257228 A1 HK1257228 A1 HK 1257228A1
Authority
HK
Hong Kong
Prior art keywords
imaging
chelating compound
chelating
compound
Prior art date
Application number
HK18116264.5A
Other languages
English (en)
Inventor
Christopher Paul Leamon
Original Assignee
Endocyte Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Endocyte Inc filed Critical Endocyte Inc
Publication of HK1257228A1 publication Critical patent/HK1257228A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HK18116264.5A 2015-08-14 2018-12-19 用螯合物成像的方法 HK1257228A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562205621P 2015-08-14 2015-08-14
PCT/US2016/046527 WO2017030893A1 (en) 2015-08-14 2016-08-11 Method of imaging with a chelating compound

Publications (1)

Publication Number Publication Date
HK1257228A1 true HK1257228A1 (zh) 2019-10-18

Family

ID=58051942

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18116264.5A HK1257228A1 (zh) 2015-08-14 2018-12-19 用螯合物成像的方法

Country Status (5)

Country Link
US (1) US10420850B2 (zh)
EP (1) EP3334466B1 (zh)
ES (1) ES2811347T3 (zh)
HK (1) HK1257228A1 (zh)
WO (1) WO2017030893A1 (zh)

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2816110A (en) 1956-11-23 1957-12-10 Merck & Co Inc Methods for the production of substituted pteridines
US5140104A (en) 1982-03-09 1992-08-18 Cytogen Corporation Amine derivatives of folic acid analogs
US5242679A (en) 1985-01-14 1993-09-07 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
US5175343A (en) 1985-01-14 1992-12-29 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
NZ217821A (en) 1985-10-10 1989-07-27 Biotech Australia Pty Ltd Oral delivery system; complex of active agent and vitamin b12 or analogue thereof
GB8608335D0 (en) 1986-04-04 1986-05-08 Pfizer Ltd Pharmaceutically acceptable salts
EP0273085A1 (en) 1986-12-29 1988-07-06 IntraCel Corporation A method for internalizing nucleic acids into eukaryotic cells
US5053493A (en) 1987-04-02 1991-10-01 Centocor Cardiovascular Imaging Partners, L.P. Method for labeling antibodies with a metal ion
US5688488A (en) 1989-04-03 1997-11-18 Purdue Research Foundation Composition and method for tumor imaging
ES2141102T3 (es) 1991-02-08 2000-03-16 Diatide Inc Polipeptidos marcados con tecnecio-99m para la generacion de imagenes.
US6335434B1 (en) 1998-06-16 2002-01-01 Isis Pharmaceuticals, Inc., Nucleosidic and non-nucleosidic folate conjugates
US5159079A (en) 1991-12-20 1992-10-27 Eli Lilly And Company 2-piperidones as intermediates for 5-deaza-10-oxo- and 5-deaza-10-thio-5,6,7,8-tetrahydrofolic acids
US6022966A (en) 1993-11-22 2000-02-08 Neorx Corporation Pretargeting methods and compounds
JP3538221B2 (ja) 1993-11-19 2004-06-14 富士写真フイルム株式会社 定着濃厚液およびそれを用いたハロゲン化銀写真感光材料の処理方法
US6083480A (en) 1997-05-01 2000-07-04 Diatide, Inc. Calcitonin receptor binding reagents
US6093382A (en) 1998-05-16 2000-07-25 Bracco Research Usa Inc. Metal complexes derivatized with folate for use in diagnostic and therapeutic applications
US6323313B1 (en) 1999-06-01 2001-11-27 The University Of Washington Annexin derivative with endogenous chelation sites
JP5448284B2 (ja) 2000-06-02 2014-03-19 ボード・オブ・リージエンツ，ザ・ユニバーシテイ・オブ・テキサス・システム エチレンジシステイン（ｅｃ）−薬物結合体
HUP0401127A3 (en) 2001-05-02 2006-03-28 Purdue Research Foundation Treatment and diagnosis of macrophage disease
CN101648028B (zh) 2002-05-06 2012-11-21 恩多塞特公司 维生素-定向的显象剂
WO2004069159A2 (en) 2003-01-27 2004-08-19 Endocyte, Inc. Vitamin receptor binding drug delivery conjugates
JP2007526238A (ja) 2003-05-06 2007-09-13 パーデュー・リサーチ・ファウンデーション マクロファージまたは葉酸受容体を標的とする狼瘡治療法
PT2187965T (pt) 2007-08-17 2020-01-17 Purdue Research Foundation Conjugados ligando-ligante de ligação a psma e métodos para utilização
CA2790577A1 (en) 2010-02-25 2011-09-01 Purdue Research Foundation Psma binding ligand-linker conjugates and methods for using

Also Published As

Publication number Publication date
EP3334466A4 (en) 2019-03-20
US20190111162A1 (en) 2019-04-18
ES2811347T3 (es) 2021-03-11
EP3334466A1 (en) 2018-06-20
US10420850B2 (en) 2019-09-24
EP3334466B1 (en) 2020-05-13
WO2017030893A1 (en) 2017-02-23

Similar Documents

Publication Publication Date Title
HRP20201847T1 (hr) Postupak za pripremu spoja diariltiohidantoina
GB2538260B (en) A method of calibrating a sterescopic camera system
IL258400A (en) A method for shortening the sparkle
IL281292B1 (en) Processes for preparing a diarylthiohydantoin compound
HK1255832A1 (zh) 吡喃並二吡啶化合物
GB201521524D0 (en) Compound
IL249765B (en) A method for precise positioning
HK1255356A1 (zh) 連接方法
GB201511036D0 (en) Imaging method
IL259914B (en) A method for producing a benzoxazole compound
HK1257228A1 (zh) 用螯合物成像的方法
GB201522624D0 (en) A method
GB201521650D0 (en) A method
GB201508418D0 (en) Imaging method
GB201518950D0 (en) Compound
GB201710285D0 (en) Method for producing nitrogen-containing pentafluorosulfanylbenzene compound
GB201416017D0 (en) An Anticonvulsant Compound
HK1251574A1 (zh) 四氫噁庚英吡啶化合物
IL259156A (en) A method of sealing a durotomy
GB201520391D0 (en) Compound
GB201520393D0 (en) Compound
GB201515305D0 (en) Method of preventing a fall
GB201509303D0 (en) Compound
GB201504326D0 (en) A magnetic component
AU2015902274A0 (en) A method of measuring chimerism